XFOR - X4 Pharmaceuticals, Inc
3.37
0.080 2.374%
Share volume: 151,551
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.29
0.08
0.02%
Summary score
9%
Profitability
8%
Dept financing
11%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.46%
Return on assets
-18.72%
Return on sales
0%
Return on invested capital
42.62%
Total debt ratio
55.14%
Debt ratio change over timeo
0%
Current Ratio
6.92%
Quick Ratio
0%
Cash Position Ratio
6.6%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.65%
Return on assets
-8.96%
Return on sales
0%
Return on invested capital
-61.43%
Total debt ratio
24.13%
Debt ratio change over timeo
0%
Current Ratio
12.2%
Quick Ratio
0%
Cash Position Ratio
11.67%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.44%
Return on assets
-10.28%
Return on sales
0%
Return on invested capital
-69.26%
Total debt ratio
26.41%
Debt ratio change over time
0%
Current Ratio
10.19%
Quick Ratio
0%
Cash Position Ratio
9.62%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XFOR | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -26.46% | 11.55% | 5.76% | -13.17% |
| Return on assets | -18.72% | 3.57% | 4.02% | -8.16% |
| Return on sales | 0% | 42.16% | 39.53% | -204.65% |
| Return on invested capital | 42.62% | 7.99% | 5.61% | -53.4% |
| Profitability | 25% | 77% | 64% | 0% |
| Total debt ratio | 55.14% | 74.11% | 65.71% | 38.48% |
| Debt ratio change over time | 0% | 0% | 376.49% | 0% |
| Dept financing | 19% | 25% | 47% | 13% |
| Current Ratio | 12.2% | 2.02% | 2.86% | 3.17% |
| Quick Ratio | 0% | 1.71% | 2.76% | 3.11% |
| Cash Position Ratio | 11.67% | 0.76% | 2.25% | 2.96% |
| Liquididy | 50% | 40% | 40% | 46% |
| Short-term ratios | XFOR | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -13.65% | 17.94% | -1.29% | -13.17% |
| Return on assets | -8.96% | 3.67% | 1.51% | -8.16% |
| Return on sales | 0% | 37.5% | 16.39% | -204.65% |
| Return on invested capital | -61.43% | 7.17% | -0.65% | -53.4% |
| Profitability | 0% | 100% | 21% | 0% |
| Total debt ratio | 24.13% | 83.42% | 64.86% | 38.48% |
| Debt ratio change over time | 0% | 0% | 1.76% | 0% |
| Dept financing | 7% | 25% | 44% | 12% |
| Current Ratio | 12.2% | 2.02% | 2.86% | 3.17% |
| Quick Ratio | 0% | 1.71% | 2.76% | 3.11% |
| Cash Position Ratio | 11.67% | 0.76% | 2.25% | 2.96% |
| Liquididy | 50% | 20% | 33% | 38% |
